Доступ предоставлен для: Guest
Портал Begell Электронная Бибилиотека e-Книги Журналы Справочники и Сборники статей Коллекции
Forum on Immunopathological Diseases and Therapeutics
SJR: 0.309 SNIP: 0.041 CiteScore™: 0.18

ISSN Печать: 2151-8017
ISSN Онлайн: 2151-8025

Archives: Volume 1, 2010 to Volume 7, 2016

Forum on Immunopathological Diseases and Therapeutics

DOI: 10.1615/ForumImmunDisTher.2012004745
pages 341-350

Treating Colorectal Cancer with Western and Chinese Medicine

Hans Lampe
Clinic for Internal Medicine III, University of Rostock, Ernst Heydemann Str. 6, 18055 Rostock, Germany
M. Leithauser
Clinic for Internal Medicine III, University of Rostock, Ernst Heydemann Str. 6, 18055 Rostock, Germany
C. Junghanss
Clinic for Internal Medicine III, University of Rostock, Ernst Heydemann Str. 6, 18055 Rostock, Germany
M. Freund
Clinic for Internal Medicine III, University of Rostock, Ernst Heydemann Str. 6, 18055 Rostock, Germany

Краткое описание

Research into new treatment concepts has improved the clinical course of colorectal cancer (CRC) significantly over the last decades. For early stages, cure rates have reached 60% with standard treatments, and for advanced disease median survival times have been improved to more than 20 months today. Targeted therapies promise further improvements for the future. Chinese medicine (CM) has contributed some drugs to present treatment concepts and may add new strategies for the future, especially where identifiable targets are missing. Although Western medicine (WM) focused on a most precise diagnosis of tumor histology and the extent of dissemination, CM has developed functional diagnoses of disturbed body functions. And as WM aims at producing most specific targeted drugs, CM intends to stabilize disturbed body functions. A combined treatment that synergizes the specific tumor attack and the patient's stabilization seems promising. This approach only started a few decades ago. At present, the experiences and promising results from smaller studies stand against possible risks of unknown interactions. Therefore, in everyday life, Western and Chinese medicines should be used in sequence, whereas in studies and special situations the combined approach should be applied to offer possible benefits without causing unnecessary risks to the patients.